PATENT CLAIM ANALYSIS

Application Number: 16455020
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "210180"]

Abstract:
The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents R 1 , R 3 , R 6 , R 7 , and b are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.

Claim (Index 8):
The method according to  claim 1 , wherein in the compound of Formula I or pharmaceutically acceptable salt thereof, each R 2  is independently selected from the group consisting of halogen, oxo, cyano, hydroxy, optionally substituted (C 1 -C 6 )alkyl, and optionally substituted (C 1 -C 6 )alkoxy.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 100.0
- Lexical Diversity: 1.60976
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14817606', '14180463', '14804644', '16074290', '15426423']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8719960361262719
- 35 USC 102 Novelty (BERT): 0.569162003646903
- Combined Prediction Score: 0.841712632878335
- Mean Citation Score: 408.060214
- Max Citation Score: 453.0013
- Similarity Product: 421.7146416330874

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test